|
BERLIN – January 12, 2026 (NEWMEDIAWIRE) – Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, 14 January 2026, at the Westin St. Francis in San Francisco, CA, USA. Dr Harald Hasselmann, CEO of Eckert & Ziegler SE, will present the company at 17:15 PST. The presentation will be available as an audio livestream on the company’s website: https://www.ezag.com/investors/presentations/ About Eckert & Ziegler. Your contact: |
BERLIN – January 12, 2026 (NEWMEDIAWIRE) – Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, 14 January 2026, at the Westin St. Francis in San Francisco, CA, USA. Dr Harald Hasselmann, CEO of Eckert & Ziegler SE, will present the company at 17:15 PST.The presentation will be available as an audio livestream on the company’s website: https://www.ezag.com/investors/presentations/After the event, the recording will be available for approximately 30 days.About Eckert & Ziegler. Eckert & Ziegler SE, with more than 1.000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Borse.Contributing to saving lives.Your contact:Eckert & Ziegler SE, Karolin Riehle, Investor RelationsRobert-Rossle-Str. 10, 13125 Berlin, GermanyTel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com
View the original release on www.newmediawire.com